298 related articles for article (PubMed ID: 10527268)
1. Splenic irradiation in myelofibrosis with myeloid metaplasia: a review.
Elliott MA; Tefferi A
Blood Rev; 1999 Sep; 13(3):163-70. PubMed ID: 10527268
[TBL] [Abstract][Full Text] [Related]
2. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
Mesa RA; Elliott MA; Tefferi A
Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
[TBL] [Abstract][Full Text] [Related]
3. [Symptomatic irradiation therapy of the spleen in advanced osteomyelosclerosis].
Slanina J; Vondraczek A; Wannenmacher M
Dtsch Med Wochenschr; 1986 Jul; 111(30):1144-50. PubMed ID: 2426078
[TBL] [Abstract][Full Text] [Related]
4. Splenectomy for agnogenic myeloid metaplasia.
Coon WW; Liepman MK
Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
[TBL] [Abstract][Full Text] [Related]
5. [Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases].
Sciascia R; Mazza P; Tondi L
Radiol Med; 1988; 76(1-2):87-90. PubMed ID: 3399713
[TBL] [Abstract][Full Text] [Related]
6. Palliative splenectomy in myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Leuk Lymphoma; 2001; 42(5):901-11. PubMed ID: 11697645
[TBL] [Abstract][Full Text] [Related]
7. Splenic irradiation as a component of a reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in myelofibrosis with massive splenomegaly.
Ito T; Akagi K; Kondo T; Kawabata H; Ichinohe T; Takaori-Kondo A
Tohoku J Exp Med; 2012 Dec; 228(4):295-9. PubMed ID: 23117264
[TBL] [Abstract][Full Text] [Related]
8. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia.
Petroianu A
Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopically assisted splenectomy following preoperative splenic artery embolization using contour emboli for myelofibrosis with massive splenomegaly.
Iwase K; Higaki J; Mikata S; Tanaka Y; Yoshikawa M; Hori S; Osuga K; Kosugi S; Tamaki T; Kamiike W
Surg Laparosc Endosc Percutan Tech; 1999 Jun; 9(3):197-202. PubMed ID: 10804000
[TBL] [Abstract][Full Text] [Related]
10. Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
Sankar K; Pettit K
Curr Hematol Malig Rep; 2020 Oct; 15(5):391-400. PubMed ID: 32827272
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for splenomegaly.
Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R
JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863
[TBL] [Abstract][Full Text] [Related]
12. Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.
Tefferi A
Semin Hematol; 2003 Jan; 40(1 Suppl 1):18-21. PubMed ID: 12682877
[TBL] [Abstract][Full Text] [Related]
13. Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia.
Elliott MA; Chen MG; Silverstein MN; Tefferi A
Br J Haematol; 1998 Nov; 103(2):505-11. PubMed ID: 9827926
[TBL] [Abstract][Full Text] [Related]
14. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
[TBL] [Abstract][Full Text] [Related]
15. Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience.
Pistevou-Gombaki K; Zygogianni A; Kantzou I; Kyrgias G; Mystakidou K; Kouvaris J; Klonizakis I; Tsirigotis P; Pappa V; Siakantari M; Eleftheriadis N; Georgakopoulos J; Sarris G; Kelekis N; Kouloulias V
J BUON; 2015; 20(4):1132-6. PubMed ID: 26416067
[TBL] [Abstract][Full Text] [Related]
16. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
[TBL] [Abstract][Full Text] [Related]
17. Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases.
Lafaye F; Rain JD; Clot P; Najean Y
Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):359-62. PubMed ID: 7892130
[TBL] [Abstract][Full Text] [Related]
18. Palliative goals, patient selection, and perioperative platelet management: outcomes and lessons from 3 decades of splenectomy for myelofibrosis with myeloid metaplasia at the Mayo Clinic.
Mesa RA; Nagorney DS; Schwager S; Allred J; Tefferi A
Cancer; 2006 Jul; 107(2):361-70. PubMed ID: 16770787
[TBL] [Abstract][Full Text] [Related]
19. Myelofibrosis with myeloid metaplasia: therapeutic options in 2003.
Mesa RA
Curr Hematol Rep; 2003 May; 2(3):264-70. PubMed ID: 12901349
[TBL] [Abstract][Full Text] [Related]
20. Indications and complications of splenectomy for children with sickle cell disease.
Al-Salem AH
J Pediatr Surg; 2006 Nov; 41(11):1909-15. PubMed ID: 17101369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
